Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2019 2020 2021 2022 2023 2024 2025
Months
January February March April May June July August September October November December
Previous Archive
31 January 2024 | Story Anthony Mthembu | Photo Supplied
Michelle de Lange
Michelle De Lange: The winner of the ‘Elite University Educator’ award announced at the first AICPA & CIMA CGMA Professional Awards Africa ceremony.

The University of the Free State (UFS) has proudly clinched two prestigious awards at the inaugural Chartered Global Management Accountant (CGMA) Leadership Award ceremony. Organised by the Association of International Certified Professional Accountants, comprising AICPA and CIMA, this event recognises the outstanding contributions to the finance and accounting industry on the continent.

Top university accolade

UFS secured the coveted CGMA Leadership Award for ‘Excellent University Partner (Top 10 in Africa).’ This accolade underscores the institution's commitment to advancing the finance and accounting sector. The presentation took place at the awards ceremony held in Johannesburg on 24 November 2023, marking a significant achievement for the UFS.

Prof Frans Prinsloo, Vice-Dean of Learning, Teaching, Innovation, and Digitalisation in the Economic and Management Sciences (EMS) Faculty at the UFS, views the award as a testament to the alignment of the academic programmes with the standards of leading professional accountancy bodies in South Africa, including the Chartered Institute of Management Accountants (CIMA).

Prinsloo stated, “We have worked diligently to align our academic programmes with the requirements of key potential professional bodies, positioning ourselves as an educator of choice. This recognition, alongside our other accreditations, confirms our success in achieving this goal.”

A global educator recognised

Further enhancing the UFS’s recognition, Michelle de Lange, Lecturer in the School of Accountancy and Programme Coordinator of the B.Com Honours in Management Accounting, received the ‘Elite University Educator of the Year Award’ in the CGMA Leadership Award category. Nominated by her students and colleagues, De Lange expressed her honour and surprise at winning, highlighting her commitment to delivering valuable content to her students.

De Lange shared her perspective, stating, “To compete against phenomenal educators was a privilege, and winning signifies that my efforts are making a positive impact on students and colleagues alike.”

According to Prinsloo and De Lange, these accolades affirm the institution’s dedication to producing top-class accountancy and finance graduates.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept